NAD+

Liver-specific NMNAT1 deletion does not affect circulating nicotinamide or extra-hepatic NAD+ despite reduced hepatic NAD+ production.; NaR is identified as a novel molecule accumulating in LKO livers, produced by cytosolic 5'-nucleotidase II (NT5C2).; Serum NaR levels decline with aging, but oral NaR supplementation in aged mice increases serum nicotinamide and multi-organ NAD+, including kidneys.; NaR supplementation reduces kidney inflammation and albuminuria in aged mice.

NAD+ regulates energy metabolism as a co-factor and participates in transcription, stress responses, DNA repair, inflammatory responses, and post-transcriptional modifications as a substrate for sirtuins, PARP, and CD38.; With age, increased DNA damage and chronic inflammation lead to overconsumption of NAD+ via PARP and CD38.; Reduced NAD+ levels decrease sirtuin and PARP activity and impair energy metabolism, ultimately leading to aging and aging-related diseases.; The precise in vivo metabolism of NAD+ and the mechanism by which NAD+ regulates aging remain elusive, and clinical application of NAD+ supplementation therapy is still under development.

NAD+ levels fall in response to stress and can be replenished through supplementation, but much about its biology remains poorly understood.; The microbiome modulates availability of NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).; Multiple cellular compartments have distinct pools of NAD+ and NADH, and non-canonical degradation pathways exist.; Ongoing controversies in the field underscore the need for more research on NAD+ detection and metabolism in specific cells and compartments.

NAD+ declines with age in certain tissues, and this depletion contributes to various aging-related diseases.; In murine studies, NAD+ precursor supplementation elevates NAD+ levels and mitigates metabolic syndrome, enhances cardiovascular health, protects against neurodegeneration, and boosts muscular strength.; Clinical studies show NAD+ precursors efficiently increase NAD+ levels in various tissues but are insufficient to ameliorate diseases.; Orally administered NAD+ intermediates interact with the gut microbiome, highlighting a potential role for gut microbiota in NAD+ metabolism and future trials.

Acetylated Cas12a loses trans-cleavage activity and is reactivated by CobB in the presence of NAD+; HOLMES(NAD+) detects NAD+ in one step by cutting ssDNA reporters to generate fluorescence signals; The system shows both sensitivity and specificity and allows quantitative determination of intracellular NAD+ concentrations; HOLMES(NAD+) expands HOLMES applications to non-nucleic acid detection

What is NAD+?

**Mechanism of Action** NAD+ (nicotinamide adenine dinucleotide) is a central redox cofactor mediating electron transfer in oxidative phosphorylation and glycolysis. It also serves as a substrate for sirtuins (SIRT1–7), poly(ADP-ribose) polymerases (PARPs), and CD38 enzymes, linking cellular energy status to epigenetic

How does NAD+ work?

Essential redox cofactor and sirtuin/PARP substrate whose restoration is studied for mitochondrial and metabolic aging.

What is the research status of NAD+?

NAD+ is currently classified as experimental, with 47,389 research references on record. This is for research purposes only and is not medical advice.

What is the molecular weight of NAD+?

NAD+ has a molecular weight of approximately 663.4 g/mol (formula C21H27N7O14P2).